The Proteomics & Modeling Core, which will be located at the Institute of Systems Biology, will add key levels of biological information, global analysis, and data visualization capabilities to our collaborative investigations of the hepatitis C virushost system. In collaboration with the Microarray & Virology Core, the Proteomics component of this core will generate global profiles of protein levels and protein-protein interactions. Our major goals are the following:
Specific Aim 1 : To profile global protein expression in HCV-replicon cell lines, cultured fetal hepatocytes transfected with HCV RNA, and standard hepatocyte cell lines using a novel annotated peptide database (APD) technology under development at the ISB. Using an established hepatocyte-specific APD we ultimately will profile changes in global protein profiles prior to and after HCV reinfection of transplanted livers.
Specific Aim 2 : To profile protein-protein interactions in the host-virus interaction network. We will probe these predictions directly using immunopurification experiments that use HCV proteins, interferon-regulated proteins, and proteins identified by on-going APD building as target proteins. We will identify and quantify interacting components using the novel IDEnT labeling method and mass spectrometry developed at the ISB. We will resolve changes in affinity among interacting components using sequential MgCl, elutions.
Specific Aim 3 : To computationally select targets for protein-interaction profiling and analyze protein-protein interaction data to produce a host-virus interaction network scaffold. The ISB computational effort will receive processed microarray data fiom the Bioinformatics & Biostatistics core. Starting with a network based on currently available data, we will iteratively select new targets for protein-interaction profiling, evaluate the new network, and select additional targets.
Specific Aim 4 : To develop and visualize computational models that integrate mRNA and protein expression data with the host-virus network scaffold to generate predictive models of host-virus network states. Finally we intend to compute a modular model of the network and identify active subnetworks within this modular map.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
1P30DA015625-01
Application #
6555681
Study Section
Special Emphasis Panel (ZDA1)
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Britton, Laura-Mae P; Sova, Pavel; Belisle, Sarah et al. (2014) A proteomic glimpse into the initial global epigenetic changes during HIV infection. Proteomics 14:2226-30
Palermo, Robert E; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Old world monkeys and new age science: the evolution of nonhuman primate systems virology. ILAR J 54:166-80
Chang, Stewart T; Thomas, Matthew J; Sova, Pavel et al. (2013) Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection. MBio 4:e00549-12
Korth, Marcus J; Tchitchek, Nicolas; Benecke, Arndt G et al. (2013) Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses. Semin Immunol 25:228-39
Selinger, Christian; Katze, Michael G (2013) Mathematical models of viral latency. Curr Opin Virol 3:402-7
Law, G Lynn; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Drug repurposing: a better approach for infectious disease drug discovery? Curr Opin Immunol 25:588-92
Law, G Lynn; Korth, Marcus J; Benecke, Arndt G et al. (2013) Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat Rev Microbiol 11:455-66
Liu, Helene Minyi; Loo, Yueh-Ming; Horner, Stacy M et al. (2012) The mitochondrial targeting chaperone 14-3-3? regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11:528-37
Rasmussen, Angela L; Wang, I-Ming; Shuhart, Margaret C et al. (2012) Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesis. Virology 430:43-52
Tisoncik, Jennifer R; Korth, Marcus J; Simmons, Cameron P et al. (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76:16-32

Showing the most recent 10 out of 49 publications